News

Santhera shares updates on commercial rollout of AGAMREE®
Santhera Pharmaceuticals (SIX: SANN) announces the latest progress on the commercial rollout of AGAMREE® for the treatment of Duchenne Muscular Dystrophy (DMD). Funding from National Health Service ...
Morningstar5d
Santhera shares updates on commercial rollout of AGAMREE®
Pratteln, Switzerland, April 16, 2025 – Santhera Pharmaceuticals (SIX: SANN) announces the latest progress on the commercial rollout of AGAMREE® for the treatment of Duchenne Muscular Dystrophy ...
Mena FN5d
Santhera Shares Updates On Commercial Rollout Of AGAMREE®
(MENAFN- GlobeNewsWire - Nasdaq) Pratteln, Switzerland, April 16, 2025 – Santhera Pharmaceuticals (SIX: SANN) announces the latest progress on the commercial rollout of AGAMREE® for the ...
Santhera Pharmaceuticals Holding AG: Santhera shares updates on commercial rollout of AGAMREE
Santhera Pharmaceuticals (SIX: SANN) announces the latest progress on the commercial rollout of AGAMREE® for the treatment of Duchenne Muscular Dystrophy (DMD). Funding ...